Hybio Pharma Surges 20% After Announcing RWA Token Partnership with KuCoin
View all comments(0)
TradingKey – On Monday, August 4, Chinese pharmaceutical firm Hybio Pharma (SHE: 300199) saw its stock skyrocket 20% intraday, hitting the daily limit before settling around +18%, following news of a strategic partnership with KuCoin, the world’s 9th-largest crypto exchange.

Hybio Pharma Stock Chart – Source: Google
Hybio and KuCoin will co-launch a Real World Asset (RWA) tokenization pilot, focused on the future revenue rights of Hybio’s GLP-1 peptide drug pipeline.
- The token will be backed by Hybio’s proprietary R&D assets, including FDA-approved formulations and next-gen triple receptor agonists
- KuCoin will provide full-stack support: blockchain infrastructure, token issuance, on-chain revenue mapping, and global compliance
This marks China’s first pharmaceutical RWA pilot, aligning with Hong Kong’s evolving virtual asset regulations.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Like
Recommended Articles
Featured Tools
Top News
Today’s Market Recap: AI Chip Stocks Surge as AMD Market Cap Crosses $1 Trillion; Intel Rises 12%, Arm Jumps 17%, Meta Gains Over 11%

Meta Shares Surge Over 8% to Highest Since February as Connect 2026 Nears, Muse Agent May Become New AI Variable

The Week Ahead: US-China Summit in Washington, Costco Earnings and Fed Rate Path in Focus

Muse Tops US App Store Two Weeks After Launch: Downloads Exceed 730,000, Overtaking ChatGPT

OpenAI and Anthropic Near AI Model Safety Cross-Testing Agreement as Agent Loss of Control Sounds Alarm





Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.